Caputron Medical Announces FDA Cleared Mindgear Treatment For Depression, Insomnia And Anxiety

NEW YORK--(BUSINESS WIRE)--Caputron Medical, a leader in personalized medical devices, announces the release of the revolutionary mindGear headset with FDA clearances for the treatment of depression, insomnia and anxiety. Reflecting half a decade of therapy optimization and clinical testing at world leading medical centers, mindGear provides patients immediate and lasting relief through a drug free therapy.

“Neuromodulation, also called electroceuticals, is the fastest growing area in the treatment of neurological and psychiatric disorders. mindGear further establishes Caputron Medical as a leader in the personalized therapy space with a hand-held and personalized device.”

Depression, insomnia, and anxiety are serious psychiatric diseases that affect millions of Americans, either as isolated disorders or, more commonly, as a constellation of symptoms. For many patients, drug based treatments do not provide sufficient relief and cause severe side effects. mindGear is a neuromodulation therapy that is drug free and gently activates the brain in a way that encourages endogenous healing.

Jennifer Higgins, Vice President for US Sales comments: “mindGear represents a major advance in the wearable tech and digital health space. Portable, personal, and customizable, mindGear is both a consumer and medical neuromodulation device.”

mindGear is a small battery powered device that connects to the head via special hydroPod electrodes. mindGear is FDA cleared for indications spanning depression, insomnia and anxiety with further clinical trials for new indications ongoing. Users dial in a customized therapy and relax through a painless session lasting about half an hour. mindGear can be used in almost any environment including at home and at work. After over five years of clinical trials and beta testing with thousands of successful sessions, mindGear is available with prescription in the US at mindGear.CaputronMedical.com

Robin Azzam adds: “Neuromodulation, also called electroceuticals, is the fastest growing area in the treatment of neurological and psychiatric disorders. mindGear further establishes Caputron Medical as a leader in the personalized therapy space with a hand-held and personalized device.”

Caputron Medical’s award winning support team is ready to address any questions about mindGear at mindGear@caputron.com

About Caputron Medical

Caputron Medical is the leading worldwide distributor of consumer, clinical and research neurostimulation technology. We are committed to improving the field through the development and distribution of novel therapeutics and supporting innovative research devices. We work closely with researchers and doctors in trials around the world with the goal of supporting the development of new research and providing novel solutions to debilitating neuropsychiatric disorders.